Want to see SYRA full AI Analyst Report?
Syra Health Corp. Class A (SYRA) Ratios
Syra Health Corp. Class A Ratios
SYRA's free cash flow for Q2 2026 was $-718.76K. For the 2026 fiscal year, SYRA's free cash flow was increased by $5.00 and operating cash flow was $-718.76K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.06 | 5.46 | 5.25 | 0.92 | 0.84 |
| Quick Ratio | 4.06 | 5.46 | 5.25 | 0.89 | 0.84 |
| Cash Ratio | 2.39 | 3.90 | 3.60 | 0.00 | 0.22 |
| Solvency Ratio | -1.30 | -4.62 | -3.18 | -1.31 | -0.01 |
| Operating Cash Flow Ratio | -0.66 | -4.78 | -3.03 | -1.45 | -0.20 |
| Short-Term Operating Cash Flow Coverage | -3.85 | -19.18 | -14.92 | -2.99 | -0.45 |
| Net Current Asset Value | $ 2.06M | $ 2.55M | $ 3.87M | $ -182.80K | $ -161.89K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.12 | 0.05 | 0.40 | 0.64 |
| Debt-to-Equity Ratio | 0.07 | 0.16 | 0.06 | 1.32 | -47.97 |
| Debt-to-Capital Ratio | 0.06 | 0.14 | 0.06 | 0.57 | 1.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.32 | 1.28 | 1.23 | 3.27 | -75.12 |
| Debt Service Coverage Ratio | -6.65 | -21.85 | -11.89 | -2.66 | -0.02 |
| Interest Coverage Ratio | -68.15 | -241.34 | -53.79 | -73.24 | 0.00 |
| Debt to Market Cap | 0.11 | 0.11 | 0.04 | 0.04 | 0.01 |
| Interest Debt Per Share | 0.01 | 0.06 | 0.06 | 0.16 | 0.05 |
| Net Debt to EBITDA | 1.71 | 0.53 | 1.07 | -0.45 | -79.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 34.43% | 20.71% | 25.54% | 18.90% | 30.52% |
| EBIT Margin | -12.22% | -46.90% | -52.30% | -37.20% | -0.23% |
| EBITDA Margin | -11.94% | -46.11% | -51.42% | -36.93% | -0.22% |
| Operating Profit Margin | -12.51% | -47.17% | -52.36% | -37.20% | -0.23% |
| Pretax Profit Margin | -12.40% | -47.10% | -53.28% | -37.71% | -0.23% |
| Net Profit Margin | -12.40% | -47.10% | -53.28% | -37.71% | -0.23% |
| Continuous Operations Profit Margin | -12.40% | -47.10% | -53.28% | -37.71% | -0.23% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 99.12% | 99.85% | 101.76% | 101.36% | 100.00% |
| Return on Assets (ROA) | -32.32% | -102.17% | -59.68% | -91.31% | -0.61% |
| Return on Equity (ROE) | -42.72% | -130.59% | -73.22% | -298.29% | 45.89% |
| Return on Capital Employed (ROCE) | -43.10% | -122.80% | -71.95% | -270.23% | -3.88% |
| Return on Invested Capital (ROIC) | -40.34% | -113.07% | -67.76% | -127.04% | -0.98% |
| Return on Tangible Assets | -32.32% | -102.17% | -59.68% | -91.31% | -0.61% |
| Earnings Yield | -87.94% | -125.63% | -59.31% | -12.05% | -0.02% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.87 | 11.72 | 4.66 | 4.17 | 5.00 |
| Payables Turnover | 14.83 | 62.24 | 8.87 | 10.46 | 7.79 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 96.51 | 0.00 |
| Fixed Asset Turnover | 210.14 | 24.52 | 38.79 | 18.93 | 9.11 |
| Asset Turnover | 2.61 | 2.17 | 1.12 | 2.42 | 2.63 |
| Working Capital Turnover Ratio | 3.01 | 2.42 | 2.94 | -59.21 | -37.95 |
| Cash Conversion Cycle | 21.78 | 25.27 | 37.23 | 56.35 | 26.19 |
| Days of Sales Outstanding | 46.39 | 31.13 | 78.38 | 87.47 | 73.04 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 3.78 | 0.00 |
| Days of Payables Outstanding | 24.61 | 5.86 | 41.15 | 34.90 | 46.85 |
| Operating Cycle | 46.39 | 31.13 | 78.38 | 91.25 | 73.04 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.04 | -0.40 | -0.57 | -0.38 | -0.01 |
| Free Cash Flow Per Share | -0.04 | -0.41 | -0.57 | -0.40 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -4184.54 | -263.89 | -180.91 | -18.51 | -14.02 |
| Capital Expenditure Coverage Ratio | -4184.54 | -263.89 | -180.91 | -18.51 | -14.02 |
| Operating Cash Flow Coverage Ratio | -3.11 | -6.49 | -11.12 | -2.40 | -0.26 |
| Operating Cash Flow to Sales Ratio | -0.06 | -0.37 | -0.50 | -0.40 | -0.06 |
| Free Cash Flow Yield | -43.94% | -98.36% | -56.00% | -13.45% | -0.43% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.14 | -0.79 | -1.69 | -8.30 | -6660.82 |
| Price-to-Sales (P/S) Ratio | 0.14 | 0.37 | 0.90 | 3.13 | 15.49 |
| Price-to-Book (P/B) Ratio | 0.49 | 1.04 | 1.23 | 24.76 | -3056.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.28 | -1.02 | -1.79 | -7.43 | -231.22 |
| Price-to-Operating Cash Flow Ratio | -2.28 | -1.02 | -1.80 | -7.83 | -247.71 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.06 | -0.03 | -0.00 | 233.13 |
| Enterprise Value Multiple | 0.52 | -0.28 | -0.68 | -8.92 | -7188.53 |
| Enterprise Value | -451.64K | 1.05M | 1.92M | 18.51M | 22.09M |
| EV to EBITDA | 0.52 | -0.28 | -0.68 | -8.92 | -7188.53 |
| EV to Sales | -0.06 | 0.13 | 0.35 | 3.30 | 15.67 |
| EV to Free Cash Flow | 1.01 | -0.36 | -0.69 | -7.83 | -233.79 |
| EV to Operating Cash Flow | 1.01 | -0.36 | -0.70 | -8.25 | -250.46 |
| Tangible Book Value Per Share | 0.18 | 0.40 | 0.82 | 0.12 | -0.00 |
| Shareholders’ Equity Per Share | 0.18 | 0.40 | 0.82 | 0.12 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.61 | 1.10 | 1.13 | 0.96 | 0.19 |
| Net Income Per Share | -0.08 | -0.52 | -0.60 | -0.36 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.00 | 1.02 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.01 | 0.07 | 0.04 | 0.00 | 0.00 |
| SG&A to Revenue | 0.46 | 0.18 | 0.73 | 0.55 | 0.30 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Income Quality | 0.50 | 0.78 | 0.94 | 1.06 | 26.89 |
Currency in USD